Comparison of Sacubitril/Valsartan vs. Ramipril in Acute Myocardial Infarction: WIN-Ratio Analysis

The PARADISE-MI trial compared Sacubitril/Valsartan and Ramipril in patients with acute myocardial infarction. The primary outcome of cardiovascular death, heart failure hospitalization, or outpatient heart failure showed no significant difference between the two treatments. Detailed event rates and

0 views • 20 slides